Skip to content
Trial Eligibility
Menu

Crohn's Disease Clinical Trials near Los Angeles, CA

22 studies for Crohn's Disease are recruiting at 56 sites within 50 miles of Los Angeles, California, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Crohn's Disease trials in the US or all trials near Los Angeles.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Crohn's Disease studies enrolling near Los Angeles

Showing 22 studies, nearest first.
  1. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

    NCT07184931

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: GastroIntestinal Bioscience - Los Angeles-Site Number: 8400019 (Los Angeles, CA); TLC Clinical Research Inc.-Site Number: 8400030 (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  2. A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

    NCT06430801

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: Cedars Sinai Medical Center ( Site 5080) (Los Angeles, CA); UCLA Clinical & Translational Research Center (CTRC) ( Site 5116) (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  3. A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

    NCT07196722

    • Phase 2/3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: GastroIntestinal Bioscience (Los Angeles, CA); TLC Clinical Research Inc (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  4. A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

    NCT07499232

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: GastroIntestinal Bioscience (Los Angeles, CA); TLC Clinical Research Inc (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  5. Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

    NCT05230173

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Cedars-Sinai (Los Angeles, CA); Hoag Hospital (Irvine, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  6. A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

    NCT06045754

    • Phase 4
    • Ages 18 to 70 years
    • Sex: All

    Nearest sites: Cedars-Sinai Medical Center (Los Angeles, CA); Hoag Hospital Newport Beach (Newport Beach, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  7. Stem Cell Transplantation in Crohn's Disease

    NCT04224558

    • Phase 1/2
    • Ages 13 to 28 years
    • Sex: All

    Nearest site: Cedars-Sinai Medical Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  8. Precise Infliximab Exposure and Pharmacodynamic Control

    NCT05660746

    • Phase 2/3
    • Ages 6 to 22 years
    • Sex: All

    Nearest site: Children's Hospital of Los Angeles (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

    NCT05781152

    • Phase 4
    • Ages 6 to 17 years
    • Sex: All

    Nearest site: Cedars-Sinai (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

    NCT05923073

    • Phase 3
    • Ages 2 to 17 years
    • Sex: All

    Nearest site: Cedars Sinai Medical Center (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. Impact of Prebiotics in Ulcerative Colitis

    NCT06495658

    • Interventional
    • Ages 18 to 85 years
    • Sex: All

    Nearest site: UCLA (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

    NCT07483073

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: Biopharma Informatic, LLC (Los Angeles, CA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

    NCT06819878

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: 310 Clinical Research (Inglewood, CA); United Gastroenterologists (Los Alamitos, CA)

    Distance to nearest recruiting site
    ~9 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  14. Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

    NCT06937099

    • Phase 3
    • Ages 18 to 70 years
    • Sex: All

    Nearest sites: Cedars-Sinai Medical Center (Beverly Hills, CA); United Medical Doctors - Los Alamitos (Los Alamitos, CA)

    Distance to nearest recruiting site
    ~9 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  15. Urine Metabolites in the Diagnosis of Disease

    NCT06710067

    • Observational
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Digestive Health Associates (Santa Monica, CA); Westside Gastro Care (Santa Monica, CA)

    Distance to nearest recruiting site
    ~14 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  16. Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

    NCT07697456

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: United Medical Doctors - Los Alamitos /ID# 281125 (Los Alamitos, CA); Clinnova Research /ID# 280509 (Anaheim, CA)

    Distance to nearest recruiting site
    ~20 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  17. A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

    NCT07577843

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: United Medical Doctors (Los Alamitos, CA); Clinnova Research (Anaheim, CA)

    Distance to nearest recruiting site
    ~20 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  18. A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

    NCT06100289

    • Phase 3
    • Ages 2 to 17 years
    • Sex: All

    Nearest site: Children's Hospital Of Orange County (Orange, CA)

    Distance to nearest recruiting site
    ~29 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. Distance to nearest recruiting site
    ~29 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

    NCT06819891

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: Amicis Research Center (Santa Clarita, CA); Hoag Memorial Hospital Presbyterian;Hoag Center for Research and Education (Newport Beach, CA)

    Distance to nearest recruiting site
    ~29 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  21. A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

    NCT06226883

    • Phase 2
    • Ages 18 to 85 years
    • Sex: All

    Nearest site: Gastro Care Institute (Lancaster, CA)

    Distance to nearest recruiting site
    ~45 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease

    NCT06958536

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Investigational Site Number: 8400001 (Lancaster, CA)

    Distance to nearest recruiting site
    ~45 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Crohn's Disease clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.